Compare EVO & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | TDOC |
|---|---|---|
| Founded | 1993 | 2002 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2021 | 2015 |
| Metric | EVO | TDOC |
|---|---|---|
| Price | $3.67 | $5.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $7.00 | ★ $9.42 |
| AVG Volume (30 Days) | 68.7K | ★ 6.3M |
| Earning Date | 11-05-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $887,396,457.00 | ★ $2,528,199,000.00 |
| Revenue This Year | N/A | $0.13 |
| Revenue Next Year | $8.52 | $1.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.84 | $5.56 |
| 52 Week High | $4.80 | $15.21 |
| Indicator | EVO | TDOC |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 24.67 |
| Support Level | $3.53 | $6.06 |
| Resistance Level | $3.81 | $6.51 |
| Average True Range (ATR) | 0.08 | 0.28 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 54.17 | 2.68 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.